MaxCyte, Inc. (MXCT.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
At close: 05:13PM BST
| Previous close | 367.50 |
| Open | 368.60 |
| Bid | 370.00 x 0 |
| Ask | 385.00 x 0 |
| Day's range | 358.00 - 380.00 |
| 52-week range | 328.50 - 1,235.00 |
| Volume | |
| Avg. volume | 90,861 |
| Market cap | 372.853M |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -14.80 |
| Earnings date | 18 Apr 2022 - 22 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.18 |
- Simply Wall St.
MaxCyte (LON:MXCT) pulls back 22% this week, but still delivers shareholders solid 28% CAGR over 3 years
MaxCyte, Inc. ( LON:MXCT ) shareholders might be concerned after seeing the share price drop 28% in the last quarter...
- Motley Fool
MaxCyte, Inc. (MXCT) Q1 2022 Earnings Call Transcript
My name is Sean Menarguez, and I'm the director of investor relations here at MaxCyte. On the call from MaxCyte, we have Doug Doerfler, president and chief executive officer; and Ron Holtz, interim chief financial officer.
- Motley Fool
MaxCyte, Inc. (MXCT) Q4 2021 Earnings Call Transcript
Thank you for standing by, and welcome to MaxCyte's fourth quarter and full year 2021 earnings conference call. On the call from MaxCyte, we have Doug Doerfler, chief executive officer; and Amanda Murphy, chief financial officer. Earlier today, MaxCyte released financial results for the fourth quarter and full year ended December 31, 2021.
© 2022 Yahoo. All rights reserved.
